Countries covered: North America
Introduction:
The North American facial injectable market, comprising revenues from the sale of botulinum toxin (BTX) and dermal filler products-including hyaluronic acid (HA) dermal fillers and particle and polymer fillers (PPF)-in the US and Canada, experienced strong postrecession recovery in 2010. Through 2015, market gains will accelerate as disposable incomes increase and consumer demand for anti-aging treatments climbs. Entry of new products will stimulate sales through improved product selection and increased public awareness; however, subsequent competitive pricing pressures will see average selling prices (ASPs) decline, thus curbing market expansion. Nevertheless, driven by increasing unit sales, both North American markets will expand over the forecast period. The US market will experience strong growth owing to a more aesthetically conscious population and the entrance of notable new products while the Canadian market will exhibit slightly slower growth because Canadian consumers tend to be more conservative and place less emphasis on physical appearance. This combination of factors will lead to robust overall market growth and North America will continue to be a steady source of revenues in the global facial injectable market over the forecast period.
Questions Answered in This Report:
- The facial injectables market suffered greatly during the 2008/2009 economic recession. In 2010, however, the market began to recover. What factors are driving this upturn? How will market recovery and growth differ across North America? When will the market return to pre-recession levels?
- Physicians and estheticians in North America are increasingly offering BTX and dermal filler treatments in combination with each other as well as in conjunction with other cosmetic procedures to enhance the aesthetic result and duration of cosmetic effects of these procedures. What are competitors doing to capitalize on the trend toward combination treatments? Will the trend toward combination treatments affect sales of facial injectable products? Which competitors are best positioned to benefit from this trend?
- There is a growing trend toward clinical adoption of aesthetic facial injectable procedures, with physicians of different specialties increasingly providing treatments. Which physician specialties are adopting facial injectables? Why would a physician choose to begin providing these services? How will this adoption of facial injectables by a wider variety of physicians affect procedural growth?
- In early 2009, Medicis Pharmaceutical received Food and Drug Administration approval to market Ipsen's BTX product, Dysport, for aesthetic indications. What effect did Dysport's launch have on competitor BOTOX Cosmetic's market share? How did Medicis drive sales in this market that readily associates BTX with the BOTOX brand? What changes will new entrants bring to the BTX market throughout the forecast period?
- Patients concerned about their aging appearance are increasingly seeking out treatment from physicians and alternative providers, such as medispas. How are patients learning about products in this market? Which companies are most effectively drawing on increased patient demand to drive sales? How are companies leveraging celebrities and pop culture to increase sales?
Scope:
Regions covered: US, Canada
Procedure segmentation: Our analysis uses the following breakdown of procedures:
- By segment (BTX, dermal fillers)
- By country (BTX, HA, PPF)
- By facial area and segment
- By facial area and country
Market segmentation: Our analysis uses the following breakdown of the market:
- BTX
- Dermal Fillers
- HA Dermal Fillers
- PPF
Market forecast features: Based on extensive secondary research and primary research with clinicians and industry professionals, we use our proprietary forecasting model to provide an in-depth examination of current and future trends in procedure volumes, unit sales, ASPs, and market values over a 7-year period (2009-2015).
Competitive analysis: We provide a detailed analysis of the competitive landscape in the market, as well as market shares and qualitative discussions of the leading competitors in each market segment.
|
- EXECUTIVE SUMMARY
- METHODOLOGY
- 1.0 NORTH AMERICAN FACIAL INJECTABLE MARKET
- 1.1 Market Overview
- 1.2 Market Analysis
- 1.2.1 Key Report Updates
- 1.2.2 Product Overview
- 1.2.3 Procedures
- 1.2.3.1 Market Definitions
- 1.2.3.2 Procedures by Injector Type
- 1.2.3.3 Procedures by Injectable Type
- 1.2.3.4 Procedures by Facial Area
- Forehead
- Glabellar Complex
- Periorbital Area
- Cheek
- Nasolabial Fold
- Mouth Area
- Lip
- Other
- 1.2.4 Market Forecast
- 1.2.4.1 US Facial Injectable Market
- 1.2.4.2 Canadian Facial Injectable Market
- 1.2.5 Market Drivers and Limiters
- 1.2.5.1 Market Drivers
- 1.2.5.2 Market Limiters
- 1.3 Competitive Analysis
- 1.3.1 Competitive Landscape
- 1.3.2 Market Shares
- 1.3.3 Competitor Discussions (in Alphabetical Order)
- Allergan
- BioForm Medical
- Ipsen
- Medicis Pharmaceutical
- Q-Med
- Other
- 1.3.4 Emerging Competitors (in Alphabetical Order)
- Anika Therapeutics
- Anteis
- Contura
- Laboratoires TEOXANE
- Mentor
- Merz Pharmaceuticals
- Prollenium Medical Technologies
- 2.0 BOTULINUM TOXIN MARKET
- 2.1 Market Overview
- 2.2 Market Analysis
- 2.2.1 Product Overview
- 2.2.2 Botulinum Toxin Procedures by Facial Area
- 2.2.3 Market Forecast
- 2.2.4 Market Drivers and Limiters
- 2.2.4.1 Market Drivers
- 2.2.4.2 Market Limiters
- 2.3 Competitive Analysis
- 2.3.1 Competitive Landscape
- 2.3.2 Market Shares
- 3.0 DERMAL FILLER MARKET
- 3.1 Market Overview
- 3.2 Market Analysis
- 3.2.1 Product Overview
- 3.2.1.1 Hyaluronic Acid Fillers
- 3.2.1.2 Particle and Polymer Fillers
- 3.2.2 Dermal Filler Procedures by Facial Area
- 3.2.2.1 Hyaluronic Acid Fillers by Facial Area
- 3.2.2.2 Particle and Polymer Fillers by Facial Area
- 3.2.3 Market Forecast
- 3.2.3.1 Hyaluronic Acid Filler Market
- 3.2.3.2 Particle and Polymer Filler Market
- 3.2.4 Market Drivers and Limiters
- 3.2.4.1 Market Drivers
- 3.2.4.2 Market Limiters
- 3.3 Competitive Analysis
- 3.3.1 Competitive Landscape
- 3.3.1.1 Hyaluronic Acid Filler Segment
- 3.3.1.2 Particle and Polymer Filler Segment
- 3.3.2 Market Shares
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- APPENDIX B: SUPPLEMENTAL FIGURES
- LIST OF FIGURES AND TABLES
- EXECUTIVE SUMMARY
- Figure 1: Facial Injectable Market, by Segment, North America (US$), 2009-2015
- Figure 2: BTX Market, by Country, North America (US$), 2009-2015
- Figure 3: Dermal Filler Market, North America (US$), 2009-2015
- Table 1: Companies Mentioned in This Report
- METHODOLOGY
- Table 2: Average Currency Exchange Rates, 2009
- 1.0 NORTH AMERICAN FACIAL INJECTABLE MARKET
- Figure 4: Facial Injectable Market, by Segment, North America (US$), 2009-2015
- Table 3: Key Report Updates, 2011
- Table 4: Current Facial Injectable Products, North America, 2010
- Table 5: Common Facial Injectable Indications, by Type, North America, 2010
- Table 6: Volume of Facial Injectable Product per Procedure, by Product
- Table 7: Facial Injectable Procedures, by Segment, North America, 2009-2015
- Table 8: Facial Injectable Procedures, by Country, North America, 2009-2015
- Table 9: BTX Procedures, by Country, North America, 2009-2015
- Table 10: Dermal Filler Procedures, by Country, North America, 2009-2015
- Table 11: HA Dermal Filler Procedures, by Country, North America, 2009-2015
- Table 12: PPF Dermal Filler Procedures, by Country, North America, 2009-2015
- Table 13: Facial Injectable Procedure Breakdown, by Facial Area and Segment, North America, 2010
- Table 14: Facial Injectable Procedure Breakdown, by Facial Area and Country, North America, 2010
- Figure 5: Facial Injectable Market, by Country, North America (US$), 2009-2015
- Table 15: Facial Injectable Market, by Segment, North America (US$), 2009-2015
- Table 16: Facial Injectable Market Growth, by Segment, North America, 2010-2015
- Table 17: Facial Injectable Market, by Segment, as a % of Total, North America, 2009-2015
- Table 18: Facial Injectable Market, by Country, North America (US$ and CA$), 2009-2015
- Table 19: Facial Injectable Market Growth, by Country, North America, 2010-2015
- Table 20: Facial Injectable Market, by Country, as a % of Total, North America 2009-2015
- Table 21: Drivers and Limiters of the Facial Injectable Market, North America
- Figure 6: Leading Competitors in the Facial Injectable Market, as a % of Total, North America, 2010
- Table 22: Leading Competitors in the Facial Injectable Market, by Segment, as a % of Total, North America, 2010
- 2.0 BOTULINUM TOXIN MARKET
- Figure 7: BTX Market, by Country, North America (US$), 2009-2015
- Table 23: Current and Emerging Cosmetic BTX Products, North America, 2010
- Table 24: BTX Procedure Breakdown, by Facial Area and Country, as a % of Total, North America, 2010
- Table 25: BTX Market, by Country, North America (US$ and CA$), 2009-2015
- Table 26: BTX Market Growth, by Country, North America, 2010-2015
- Table 27: BTX Market, by Country, as a % of Total, North America, 2009-2015
- Table 28: Drivers and Limiters of the Facial Injectable Market, North America
- Table 29: Leading Competitors in BTX Market, by Country, as a % of Total, North America, 2010
- 3.0 DERMAL FILLER MARKET
- Figure 8: Dermal Filler Market, by Segment, as a % of Total, North America, 2010 and 2015
- Table 30: Current and Emerging HA Dermal Filler Products, North America, 2010
- Table 31: Current and Emerging PPF Products, North America, 2010
- Table 32: HA Procedure Breakdown, by Facial Area and Country, as a % of Total, North America, 2010
- Table 33: PPF Procedure Breakdown, by Facial Area and Country, as a % of Total, North America, 2010
- Table 34: Dermal Filler Market, by Segment, North America (US$), 2009-2015
- Table 35: Dermal Filler Market Growth, by Segment, North America, 2010-2015
- Table 36: Dermal Filler Market, by Segment, as a % of Total, North America, 2009-2015
- Table 37: Dermal Filler Market, by Country, North America (US$ and CA$), 2009-2015
- Table 38: Dermal Filler Market Growth, by Country, North America, 2010-2015
- Table 39: Dermal Filler Market, by Country, as a % of Total, North America, 2009-2015
- Table 40: HA Dermal Filler Market, by Country, North America (US$ and CA$), 2009-2015
- Table 41: HA Dermal Filler Market Growth, by Country, North America, 2010-2015
- Table 42: HA Dermal Filler Market, by Country, as a % of Total, North America, 2009-2015
- Table 43: PPF Market, by Country, North America (US$ and CA$), 2009-2015
- Table 44: PPF Market Growth, by Country, North America, 2010-2015
- Table 45: PPF Market, by Country, as a % of Total, North America, 2009-2015
- Table 46: Drivers and Limiters of the Dermal Filler Market, North America
- Table 47: Leading Competitors in the Dermal Filler Market, by Segment, as a % of Total, North America, 2010
- Table 48: Leading Competitors in the HA Dermal Filler Market, by Country, as a % of Total, North America, 2010
- Table 49: Leading Competitors in the PPF Market, by Country, as a % of Total, North America, 2010
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- MRG Acronyms and Initialisms
- APPENDIX B: SUPPLEMENTAL FIGURES
- Figure 9: Facial Injectable Market, by Segment, North America (US$), 2009-2015 (Detailed Format)
- Figure 10: BTX Market, by Country, North America (US$), 2009-2015 (Detailed Format)
- Figure 11: Dermal Filler Market, North America (US$), 2009-2015 (Detailed Format)
More North America Dermatology Reports
Medicated Skin Care in the US by
Euromonitor International
Medicated skin care continued to benefit from growing consumer demand in a variety of specialty/niche segments. Hair loss treatments, for example, continued to benefit from ...
U.S. Skin Cancer Market by
Frost & Sullivan
This research service analyzes the U.S. skin cancer therapeutics market. Market drivers, restraints and challenges faced by industry participants are analyzed. Revenue forecasts for marketed ...
Medicated Skin Care - Canada by
Euromonitor International
Medicated skin care grew 2% during 2010, reaching C$372 million in current value terms. Changes in demographic and lifestyle (ie diet, physical activities) trends amongst ...
Freedonia Focus on Cosmetic Surgery Products by
Freedonia Focus
This report discusses demand for cosmetic surgery products in the US for the years 2004 and 2009, with forecasts for 2014. Topics covered include ...
Cosmetic Surgery Products by
Freedonia Group Inc
US demand to grow 6.5% annually through 2014 Demand for products used in cosmeticsurgery is forecast to increase 6.5 percentper year to $2.8 billion in 2014, ...
See all reports like this >>
More North America Reports
Spirits – Mexico – a snapshot (2011) by
Mintel - Snapshots
Spirits in Mexico by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers all ...
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country RiskLine Report: Mexico by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country RiskLine Report: Canada by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
See all reports like this >>
Share this report
Other tasks Related Markets Dermatology Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
